Technology Initiator Fund supports researchers developing early-stage technologies, from molecular detection to wearable sensing, with significant potential to advance precision health.
Funder: University of Notre Dame
Due Dates: November 9, 2026 (Application deadline, 11:59 PM)
Funding Amounts: $30,000–$40,000 per award; multiple awards anticipated
Summary: Supports early-stage development of new technologies with significant potential to advance precision health.
The Technology Initiator Fund is administered by the University of Notre Dame’s Berthiaume Institute for Precision Health (BIPH). It supports the early-stage development of new technologies with significant potential for impact in precision health. For the Fall 2026 funding cycle, BIPH anticipates supporting multiple projects.
The program emphasizes scientific excellence, relevance to its objectives, and the feasibility and impact of proposed technologies. Review also considers technology translation, where applicable, and the capacity to attract sustainable external support or leverage existing resources. Previously funded work spans molecular detection platforms, noninvasive wearable sensing, fluorescent dyes, antiviral nanomaterials, and biosensing technologies for disease prediction.